Life Science Services
Partnering with providers on front lines of care to improve population health
Greenway Health offers various clinical services to enable providers to improve the medication adherence of their patients and enhance overall quality of care.
The high cost of medications, high-deductible health plans and other external factors contribute to decreased medication adherence. Greenway’s medication adherence solutions provide practices with point-of-care tools to combat those challenges and to improve patient care and medication adherence without disturbing workflows.
Passing savings on to patients
A service once provided by pharmaceutical sales representatives, Greenway’s integrated eCoupon solution is made available within your current ePrescribing workflow.
Through eCoupons, practices can offer patients financial assistance for prescribed medications in the form of copay support, free 30-day trials or capped copayments provided by the manufacturer.
Value of eCoupons:
- Provides a cost-effective solution to address higher copays
- Reduces patients’ out-of-pocket expenses
- Increases medication adherence by offering financial assistance to your patients to drive higher fill rates on prescriptions
- Improves therapeutic outcomes
Prescription insights, where you need them
In partnership with the PDR Network, Greenway brings you up-to-date drug information, FDA safety alerts, Risk Evaluation and Mitigation Strategies (REMS), boxed warnings and other important product information — right at the point of prescribing.
PDR tools include:
- Integrated, on-screen drug reference guide
- Updated FDA labels, boxed warnings, REMS and safety alerts
- On-demand searchable database of drug labeling and safety information
- Full prescribing information
- Adverse drug reporting
Clinical Research Programs
At Greenway, we’re excited about the incredible discoveries clinical researchers can uncover using data stored in electronic health records (EHR). That’s why our EHR solutions are designed to respond to the needs of providers and researchers, enabling them to conduct and analyze clinical studies efficiently, securely and in compliance with regulatory requirements.
Our partnerships with pharmaceutical companies and Contract Research Organizations have made it possible for our customers to participate in over 50 research studies.
Partnership with Patient-Centered Outcomes Research Institute
Greenway has partnered with the prestigious Vanderbilt University Medical Center to develop the Mid-South Clinical Data Research Network (CDRN), which will fuel research with de-identified records and patient-reported outcomes from more than 30 million patients nationwide. By participating in the project, Greenway is the first EHR provider to partner with the national Patient-Centered Outcomes Research Institute (PCORI) on a research project.
The Mid-South CDRN project selected Greenway in part because of PrimeSUITE®, Greenway’s integrated EHR and practice management solution. PrimeSUITE can interoperate with many other systems, extract and aggregate de-identified patient data from EHRs, and track patients over time and across settings to build a longitudinal record.
“Greenway’s inclusion in this project is a testament to our efforts to unlock the data in EHRs and extend it across the national healthcare system to improve outcomes and contribute to population health,” Greenway CEO Tee Green has stated. “We applaud PCORI’s efforts to advance research coordination nationally and look forward to contributing to the success of this very important initiative.”
Comparative effectiveness research
By collecting evidence about the efficacy and outcomes of different treatment options, researchers can generate new scientific evidence and analytics tools to inform practitioners’ decisions.
Late-phase and post-marketing studies
Pharmaceutical research does not end when a new drug is approved; longitudinal studies further refine the safety profile of newly marketed drugs.
Population health research
Greenway is a partner in assessing the health outcomes of groups of patients to inform policies and improve patient care and outcomes.